Home › Funds › Direxion Shares ETF Trust › Direxion Daily Pharmaceutical & Medical Bull 3X ETF
Fund family: Direxion Shares ETF Trust · Filed by Direxion Shares ETF Trust (CIK 1424958) · SEC series S000050532
Ticker: PILL (C000159441)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 471 with, 12 against, 0 abstentions (not counted as with management). Shareholder proposals: 2 FOR, 7 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Direxion Shares ETF Trust’s manager page (28,641 ballot items across 25 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Direxion Shares ETF Trust | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 85.3% | 456 | 94.4% | 26,237 |
| Backed environmental and social shareholder proposals at US companies | n/a | 4 | 11.0% | 620 |
Each ballot item this fund voted is set against the votes of the other Direxion Shares ETF Trust funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most Direxion Shares ETF Trust funds on all 119 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 95.7% of this fund’s 483 such votes could be given a sector; the other 21 (4.3%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 451 | 12 | 2.7% |
| Industrials | 11 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 310 | 3 |
| Audit-related | 60 | 0 |
| Say-on-Pay | 59 | 0 |
| Compensation | 22 | 0 |
| Corporate Governance | 17 | 5 |
| Capital Structure | 12 | 0 |
| Extraordinary Transactions | 4 | 0 |
| Shareholder Rights and Defenses | 3 | 0 |
| Environment or Climate | 2 | 2 |
| Other Social Issues | 2 | 2 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Viatris Inc. | December 5, 2025 | $437,987 | 15 | 0 |
| Xeris Biopharma Holdings, Inc. | June 4, 2026 | $404,925 | 4 | 0 |
| Eli Lilly and Company | May 4, 2026 | $351,220 | 10 | 2 |
| Johnson & Johnson | April 23, 2026 | $334,883 | 15 | 1 |
| Amneal Pharmaceuticals, Inc. | May 6, 2026 | $321,953 | 12 | 0 |
| Organon & Co. | June 9, 2026 | $318,859 | 13 | 0 |
| Viatris Inc. | May 15, 2026 | $309,876 | 15 | 0 |
| Corcept Therapeutics Incorporated | May 21, 2026 | $301,038 | 11 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | For | Against |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to prepare an annual lobbying report. Shareholder proposal | Against | For |
| April 23, 2026 | Johnson & Johnson | Independent Board Chair Shareholder proposal | Against | For |
| June 9, 2026 | Pacira Biosciences, Inc. | Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Oliver Benton Curtis III Shareholder proposal | Withhold | For |
| June 9, 2026 | Pacira Biosciences, Inc. | Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Eric de Armas Shareholder proposal | Withhold | For |
| April 23, 2026 | Pfizer Inc. | Adopt an Independent Chair Policy Shareholder proposal | Against | For |
| May 5, 2026 | Bristol-Myers Squibb Company | Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| May 20, 2026 | Zoetis Inc. | Shareholder proposal to permit shareholder action by written consent. Shareholder proposal | For | Against |
Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.
491 ballot items at 62 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) voted at 62 shareholder meetings of 59 companies, on 491 ballot items in all. Where management made a recommendation, the fund followed it on 97.5% of the items and voted against it 12 times. Its most frequent area of disagreement was corporate governance (5 of its votes against management). It voted on 12 shareholder proposals. It voted FOR the board's own proposals less often than Direxion Shares ETF Trust's funds as a whole (85.3% against 94.4%). It voted the same way as most Direxion Shares ETF Trust funds on every item where a comparison was possible. 1 of its meetings was contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Direxion Shares ETF Trust’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.